Abstract
ABSTRACT: Human Bifidobacterium sp strain bifidum (B. bifidum) was administered to BALB/c lactating mice (n = 58) and their litters (n = 327 pups) to evaluate the ingested strain's adherent properties and ability to inhibit murine rotavirus (MRV) infection. ELISA and anaerobic bacteriologic techniques were used to measure MRV shedding and colonization of Bifidobacterium in the small intestine. At 13–16 d gestation, pregnant dams (and their expected litters) were randomly assigned to one of four experimental groups: 7) normal controls; 2) B. bifidum- treated only; 3) MRV-infected only; and 4) B. bifidum- treated + MRV-infected dams and litters. During the acute phase of diarrhea, 80% of small-intestine cultures in B. bifidum-treated litters were positive for the ingested B. bifidum strain compared with 24% of fecal cultures. Examination of tissue cross sections under electron microscopy revealed the ingested B. bifidum strain survived passage through the upper gastrointestinal tract and adhered to the small-intestine epithelium. After the administration of the high dose of virus, diarrhea developed in all pups, but onset was significantly delayed in B. bifidum-treated + MRV-infected litters compared with litters infected with MRV only (p < 0.02). B. bifidum-treated + MRV-infected pups demonstrated a significant reduction in MRV shedding compared with litters challenged with MRV only at d 2 to 10 after inoculation (p < 0.009). More direct studies are needed to assess mechanisms by which this anaerobe can alter the course of MRV infection at the level of gut epithelium.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Duffy, L., Zielezny, M., Riepenhoff-Talty, M. et al. Effectiveness of Bifidobacterium bifidum in Mediating the Clinical Course of Murine Rotavirus Diarrhea. Pediatr Res 35, 690–695 (1994). https://doi.org/10.1203/00006450-199406000-00014
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199406000-00014
This article is cited by
-
Effects of bifidobacteria-produced exopolysaccharides on human gut microbiota in vitro
Applied Microbiology and Biotechnology (2019)
-
A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis
European Journal of Nutrition (2017)
-
Developments in the Treatment of Rotaviral Gastroenteritis
Clinical Immunotherapeutics (1995)